The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Misbranded drugs, unapproved drugs, and companies who don’t know that ophthalmic drugs should be manufactured in a sterile environment…

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

We ask an expert for their top tips for ensuring outsourcing goes smoothly.

When it comes to influenza, chicken egg-based vaccines have achieved much, but emerging approaches are ready to fly the coop.

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!